NYSE:ATR

Aptar Reports First Quarter 2024 Results

Retrieved on: 
Thursday, April 25, 2024
Packaging, Pharmaceutical, Health, Manufacturing, Decongestant, Central Time, Investment, Emergency medicine, ERP, Therapy, Translation, Acquisition, AptarGroup, Central nervous system, Allergic rhinitis, Asthma, Growth, Beauty, Interest

Aptar Pharma had an increase in reported sales of 14% and cores sales of 13% over the prior year quarter.

Key Points: 
  • Aptar Pharma had an increase in reported sales of 14% and cores sales of 13% over the prior year quarter.
  • Sales improved for the Injectables division, rebounding from the Enterprise Resource Planning (ERP) implementation headwind that impacted the first quarter results of 2023.
  • Aptar Beauty’s reported sales were flat compared to the prior year quarter, and with currency effects core sales were down slightly.
  • There will be a conference call held on Friday, April 26, 2024 at 8:00 a.m. Central Time to discuss the company’s first quarter results for 2024.

Aptar Declares Quarterly Dividend

Retrieved on: 
Thursday, April 11, 2024
Packaging, Cosmetics, Retail, Health, Manufacturing, Pharmaceutical, Food, Beverage, AptarGroup, ATR, Central Time, Interest

AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today declared a quarterly cash dividend of $0.41 per share.

Key Points: 
  • AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today declared a quarterly cash dividend of $0.41 per share.
  • The payment date is May 16, 2024, to stockholders of record as of April 25, 2024.
  • As previously announced, Aptar will hold a conference call on Friday, April 26, 2024 at 8:00 a.m. Central Time to discuss the Company’s first quarter results for 2024.
  • Replay of the conference call can also be accessed for a limited time on the Investors page of the website.

Aptar Named a CDP Supplier Engagement Leader for the Fourth Consecutive Year

Retrieved on: 
Wednesday, March 20, 2024
General Health, Professional Services, Pharmaceutical, Sustainability, Recycling, Environment, Green Technology, Packaging, Climate Change, Environmental, Social and Governance (ESG), Manufacturing, Health, Carbon, CDP, Climate change, Innovation, ATR, Disclosure, Plastic, AptarGroup, Multimedia

AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, was named to the CDP Supplier Engagement Leaderboard, for the fourth consecutive year.

Key Points: 
  • AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, was named to the CDP Supplier Engagement Leaderboard, for the fourth consecutive year.
  • View the full release here: https://www.businesswire.com/news/home/20240320103929/en/
    Graphic: Aptar is a 2023 CDP Supplier Engagement Leader (Graphic: Business Wire)
    CDP evaluates an organization’s engagement with their suppliers on climate change.
  • By evaluating supplier engagement and recognizing best practice, CDP aims to accelerate global action on supply chain emissions.
  • “Our fourth consecutive year as a CDP Supplier Engagement Leader reflects the strong collaboration between our Sustainability, Innovation and Purchasing teams where we strategically align with suppliers that are participating in our Supplier Screening process through platforms like EcoVadis,” said Beth Holland, Aptar’s Chief Sustainability Officer.

Aptar Named One of Barron’s 100 Most Sustainable U.S. Companies for the Sixth Consecutive Year

Retrieved on: 
Thursday, February 29, 2024
Environment, Packaging, Professional Services, Manufacturing, Sustainability, Health, Pharmaceutical, General Health, Environmental, Social and Governance (ESG), Multimedia, John Macarthur (wool pioneer), Targets, Biophysical environment, Growth, Social, Disclosure, AptarGroup, ESG, CDP, Climate change, Ellen, Organization, Science Based Targets initiative, Sustainable development, MacArthur Foundation, Science, ATR, Renewable energy

AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, has been named one of Barron’s 100 Most Sustainable U.S. Companies for the sixth consecutive year and is ranked number 29 out of 100 companies for 2024.

Key Points: 
  • AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, has been named one of Barron’s 100 Most Sustainable U.S. Companies for the sixth consecutive year and is ranked number 29 out of 100 companies for 2024.
  • View the full release here: https://www.businesswire.com/news/home/20240229523803/en/
    “We are delighted to be named to Barron’s 100 Most Sustainable Companies for the sixth consecutive year for our leadership on sustainability efforts that help us, our employees, consumers, customers and community partners create a better future,” said Stephan B. Tanda, Aptar President and CEO.
  • Barron’s partnered with Calvert, a leader in ESG investing, to build the list of the most sustainable companies.
  • Barron’s full list of the 100 Most Sustainable Companies can be found here .

Aptar Signs Enterprise Agreement with Biogen to Operate and Develop Digital Health Solutions

Retrieved on: 
Friday, February 9, 2024
General Health, Manufacturing, Health, Pharmaceutical, Packaging, ATR, Lupus, AptarGroup, Digital health, Neurology, Fatigue, Multimedia, BIIB, Immunology, Patient, Neuroscience, Multiple sclerosis

Aptar Digital Health, part of AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, has entered into an enterprise agreement with Biogen Inc. (Nasdaq: BIIB) to operate and develop digital health solutions for neurological and rare diseases.

Key Points: 
  • Aptar Digital Health, part of AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, has entered into an enterprise agreement with Biogen Inc. (Nasdaq: BIIB) to operate and develop digital health solutions for neurological and rare diseases.
  • As part of the agreement, Biogen will transfer ownership of select digital health solutions to Aptar Digital Health (Aptar).
  • In addition to these solutions, Biogen and Aptar will further collaborate to potentially develop and bring to market new digital health solutions for the management of spinal muscular amyotrophy, Friedreich’s ataxia and lupus in selected countries.
  • “We are excited to leverage our end-to-end capabilities to support Biogen and enable patients and their care teams to benefit from advanced digital solutions for better disease management,” said Pierre Leurent, President, Aptar Digital Health.

Aptar Reports Fourth Quarter and Annual 2023 Results

Retrieved on: 
Thursday, February 8, 2024
Packaging, Pharmaceutical, Health, Manufacturing, Growth, ATR, Multimedia, AptarGroup, Acquisition, Cryptocurrency

Aptar reported net income of $62 million for the quarter, a 6% increase over the prior year.

Key Points: 
  • Aptar reported net income of $62 million for the quarter, a 6% increase over the prior year.
  • View the full release here: https://www.businesswire.com/news/home/20240208100452/en/
    “I am pleased to report that we delivered strong fourth quarter and full year results.
  • A big driver of this success can be attributed to our proprietary pharma dosing and dispensing systems, which reported over 20% core sales growth in the fourth quarter and double-digit growth for the year.
  • Our beauty dispensing solutions in fragrance also delivered double-digit core sales growth for 2023, rounding out a very successful year for us.

Aptar Named One of America’s Most Responsible Companies by Newsweek for the Fifth Consecutive Year

Retrieved on: 
Tuesday, January 23, 2024
Environment, Packaging, Chemicals, Plastics, Professional Services, Manufacturing, Sustainability, Green Technology, Environmental, Social and Governance (ESG), Recycling, AptarGroup, MacArthur Foundation, Statista, Ellen, Social, GRI, Responsibility, Partnership, John Macarthur (wool pioneer), Corporate social responsibility, CSR, Woman, ESG, ATR, Sustainable development, Pharmaceutical industry

AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that it has been named one of America’s Most Responsible Companies 2024 by Newsweek for the fifth consecutive year.

Key Points: 
  • AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that it has been named one of America’s Most Responsible Companies 2024 by Newsweek for the fifth consecutive year.
  • Aptar is ranked number 29 out of 600 U.S. companies and is ranked first in its industry category.
  • View the full release here: https://www.businesswire.com/news/home/20240123575188/en/
    “We are extremely proud to be recognized by Newsweek for the fifth consecutive year.
  • Newsweek’s full list of America’s Most Responsible Companies 2024 can be found here .

Aptar Declares Quarterly Dividend and Announces 2024 Annual Meeting Details

Retrieved on: 
Thursday, January 18, 2024
General Health, Manufacturing, Health, Pharmaceutical, Packaging, AptarGroup, Interest, Shareholder, ATR, Central Time

The payment date is February 22, 2024, to stockholders of record as of February 1, 2024.

Key Points: 
  • The payment date is February 22, 2024, to stockholders of record as of February 1, 2024.
  • The Board also announced that the 2024 Annual Meeting of Stockholders will be held virtually on May 1, 2024, at 9:00 a.m. Central Time.
  • The record date for stockholders entitled to vote at the meeting is March 8, 2024.
  • More details regarding accessing the meeting will be shared as we get closer to the event.

Aptar to Present at 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024

Retrieved on: 
Thursday, January 4, 2024
Biotechnology, Pharmaceutical, Health, Conference, ATR, AptarGroup, CFO

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, announced their participation at the 42nd Annual J.P. Morgan Healthcare Conference on Thursday, January 11, 2024.

Key Points: 
  • AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, announced their participation at the 42nd Annual J.P. Morgan Healthcare Conference on Thursday, January 11, 2024.
  • Stephan Tanda, President and CEO, will present at 1:30 p.m. Eastern Standard Time.
  • Bob Kuhn, Executive Vice President and CFO, and Gael Touya, President Aptar Pharma, will also be available.

Aptar Announces 2024 Quarterly Conference Call Dates

Retrieved on: 
Tuesday, January 2, 2024
General Health, Manufacturing, Health, Pharmaceutical, Packaging, Conference

Press releases will be issued on the dates noted after the close of trading on the New York Stock Exchange.

Key Points: 
  • Press releases will be issued on the dates noted after the close of trading on the New York Stock Exchange.
  • Times shown are in the Central U.S. time zone.
  • Conference calls will last approximately one hour and interested parties are invited to listen to a live webcast by visiting investors.aptar.com .
  • Replay of the conference calls can also be accessed on the Investors page of the website.